| Revenue growth | 21% YoY |
|---|---|
| Margins | EBITDA margin improved to 36.0% (Ind AS) |
| Demand visibility | Strong network expansion momentum |
| Management confidence | Strong footing beginning FY27 |
Growth
Revenue grew 21% YoY to INR 876.5 Mn; EBITDA rose 28% to INR 315.3 Mn; PAT jumped 40% to INR 128.5 Mn.
Outlook
Aggressive expansion with 4 hubs and 7 spokes upcoming in FY27; Genomics vertical expected to become a meaningful pillar.
Risks
Execution risks in new geographies (Jharkhand/Bihar) and potential schedule changes for analyst calls due to exigencies.
Last quarter's promises, checked
Delivered
- Guided 15% revenue growth → delivered 21% (= BEAT)
- Guided EBITDA margin 33% → delivered 36% (= BEAT)
- Guided regional expansion beyond WB → delivered hubs in Berhampur and Dhanbad (= BEAT)
Partly delivered
- Guided 14 centers in FY27 → delivered 4 hubs and 7 spokes in progress (= PARTIAL)
Investor Presentation filed with BSE, NSE: SURAKSHA. Summary written with AI assistance from the document.
Suraksha Diagnostic Ltd: key numbers
- Share price
- ₹320.15
- Market cap
- ₹1,667 Cr
- Revenue (annual)
- ₹310.4 Cr
- Net profit (annual)
- ₹32.19 Cr
- P/E (TTM)
- 46.6×Sector 53.1×
- Promoter holding
- 49.10%+0.00% QoQ
- FII holding
- 13.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Suraksha Diagnostic Ltd
All →Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Ltd held its 21st AGM on September 22, 2026. Members adopted financial statements, approved a final dividend, and ratified cost auditor remuneration.
Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Limited has issued a notice for its 21st Annual General Meeting scheduled for September 22, 2026, to conduct routine business and dividend declaration.
- Value
- ₹0.01 Cr
Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Limited has issued a notice for its 21st Annual General Meeting to be held on September 22, 2026, to transact key corporate business.
Suraksha Diagnostic Other Announcement
Suraksha Diagnostic informed exchanges about dispatching letters to shareholders with unregistered emails, providing web links to access the 21st AGM notice and Annual Report.
Suraksha Diagnostic Annual Report
Suraksha Diagnostic Limited has filed its Annual Report for FY 2025-26, including the notice for the 21st Annual General Meeting scheduled for September 22, 2026.
Suraksha Diagnostic Earnings Call Transcript: Key Takeaways
Suraksha Diagnostic reported a robust Q1 FY27 with 21% revenue growth and 40% PAT growth, driven by expansion in West Bengal and Jharkhand and a high-growth genomics segment.
- Call
- Guides 15% growth